ACTH Interpretation by Decade of Life

What Is ACTH and Why Does It Matter?

Adrenocorticotropic hormone is a 39-amino-acid peptide released by the anterior pituitary in response to corticotropin-releasing hormone (CRH) from the hypothalamus. Its primary job is to drive cortisol synthesis in the adrenal cortex via the hypothalamic-pituitary-adrenal (HPA) axis. [Textbook description aside, the clinical utility is blunt: if cortisol is low, ACTH tells you whether the problem originates at the pituitary/hypothalamus (low ACTH) or at the adrenal gland itself (high ACTH).]

Plasma ACTH is measured by immunoradiometric assay (IRMA) or chemiluminescent immunoassay (CLIA). Both methods require the sample to be collected into a chilled EDTA tube and processed within 15 minutes, because ACTH degrades rapidly at room temperature. A single mishandled tube is one of the most common reasons for a falsely low result.

Physiological Role

ACTH binds melanocortin-2 receptors (MC2R) on adrenocortical cells, activating cAMP signaling to increase StAR protein expression and accelerate cholesterol conversion to cortisol, DHEA-S, and androstenedione. [The adrenal response to a single ACTH pulse occurs within 2 to 5 minutes.] This speed matters clinically: acute stress, venipuncture anxiety, and even a delayed sample can shift values by 20 to 40%.

The Diurnal Rhythm

ACTH secretion is pulsatile, averaging 40 pulses per 24 hours. Peak secretion occurs between 6 a.m. And 8 a.m.; nadir is around midnight. A 2013 analysis published in the Journal of Clinical Endocrinology and Metabolism confirmed that morning ACTH values average 1.8- to 2.2-fold higher than late-evening values in healthy adults across ages 20 to 75. [1] Ordering an ACTH at 2 p.m. Without noting the time renders the result nearly uninterpretable for most clinical questions.

Standard Reference Ranges vs. Optimal Ranges

Most U.S. Clinical laboratories report a broad adult reference interval of 7 to 63 pg/mL for morning plasma ACTH. This range was derived from mixed-age cohorts and reflects the 2.5th, 97.5th percentiles of a population that includes people with subclinical HPA dysfunction.

Optimal or functional ranges used in longevity and hormone-optimization medicine are narrower. Most protocols target 10 to 45 pg/mL fasting morning ACTH in adults aged 20 to 65. Values in the 45 to 63 pg/mL zone are "within reference range" but may reflect early HPA over-activation, chronic stress burden, or subclinical primary adrenal insufficiency. [Values below 10 pg/mL warrant paired cortisol and, often, a stimulation test.]

Why the Gap Between "Normal" and "Optimal" Exists

Reference ranges are statistical constructs, not health targets. The Endocrine Society's 2016 clinical practice guideline on adrenal insufficiency states: "The lower limit of normal for morning serum cortisol is not well defined, and no consensus ACTH threshold for diagnosing secondary adrenal insufficiency has been established." [2] That admission reflects real heterogeneity in assay calibration, collection practice, and population age distribution across the studies that built the reference databases.

A 2020 systematic review in the European Journal of Endocrinology pooled data from 14 studies (N=3,847 healthy controls) and found reference interval upper limits ranging from 46 to 80 pg/mL across laboratories using different immunoassay platforms. [3] Clinicians relying on a single laboratory's cut-off without considering assay methodology may misclassify roughly 8 to 12% of patients.

ACTH by Decade of Life

Age-specific interpretation is the core of this article. The sections below synthesize published cohort data, Endocrine Society guidance, and HealthRX's internal clinical dataset to provide decade-specific context.

Ages 18 to 29: Establishing Baseline

In healthy adults aged 18 to 29, morning plasma ACTH typically falls between 10 and 50 pg/mL, with a mean around 22 to 26 pg/mL in well-designed cohort studies. HPA axis pulsatility is strong, diurnal amplitude is at its lifetime peak, and cortisol awakening response (CAR) is strong.

Clinically, the most common reason to check ACTH in this decade is evaluation of secondary amenorrhea, unexplained fatigue, or suspicion of Addison disease after an abnormal cortisol stimulation test. A value below 5 pg/mL in an 18 to 29-year-old who is not on exogenous steroids is a red flag for pituitary pathology and warrants MRI of the sella.

A 2019 prospective study in 247 healthy university students (mean age 22) measured fasting 8 a.m. ACTH at 21.4 ± 8.3 pg/mL (mean ± SD). [4] This narrow spread reinforces that significant deviation from the mid-20s range deserves attention, even when still within the broad laboratory reference interval.

Ages 30 to 39: Stress Load and First Functional Shifts

Mean morning ACTH remains 20 to 28 pg/mL in this decade in non-stressed, medication-free adults. However, chronic occupational and psychosocial stress can push values toward 35 to 55 pg/mL without producing overt disease. The HPA axis in this decade responds most sensitively to chronic sleep restriction. A landmark 2010 SLEEP journal study (N=392) demonstrated that adults averaging <6 hours of sleep per night showed mean morning ACTH 18% higher than matched controls sleeping 7 to 9 hours. [5]

Clinicians evaluating hormonal optimization in patients aged 30 to 39 should note that an ACTH above 40 pg/mL in the absence of other findings often reflects lifestyle-driven HPA over-activation rather than adrenal pathology. Repeating the test after 2 weeks of improved sleep hygiene can resolve the picture without further workup.

Ages 40 to 49: Perimenopause, Andropause, and HPA Recalibration

The 40s introduce meaningful gonadal hormone decline in both sexes, and the HPA axis compensates. Estrogen and testosterone both modulate CRH sensitivity; as they fall, HPA reactivity can increase. Published reference data for this decade show mean fasting ACTH values of 22 to 32 pg/mL, with a slight upward shift compared to the 20s. [1]

Women entering perimenopause (typically ages 45 to 52) may show episodic ACTH elevations of 60 to 90 pg/mL during hot flashes, driven by noradrenergic activation of CRH neurons. These are not pathological, but they can confound a single morning draw. The Menopause Society recommends noting menopausal status on any hormonal lab requisition. [6]

For men, the testosterone-cortisol ratio declines in this decade, and ACTH values trending above 40 pg/mL paired with low morning testosterone warrant consideration of HPA hyperactivation as a contributor to functional hypogonadism.

Ages 50 to 59: Adrenal Aging Begins

ACTH mean values in published cohorts for ages 50 to 59 cluster around 24 to 36 pg/mL. The adrenal cortex begins to show histological changes (nodularity, reduced zona glomerulosa volume) that can alter its responsiveness to ACTH stimulation. [A 250-mcg cosyntropin stimulation test, not just a basal ACTH, is the appropriate diagnostic tool when adrenal reserve is in question.]

A 2015 cross-sectional study of 1,024 adults across ages 40 to 80, published in the Journal of Clinical Endocrinology and Metabolism, found that basal morning ACTH increased by approximately 0.8 pg/mL per decade after age 50, while peak cosyntropin-stimulated cortisol declined by 15 to 20% per decade. [7] This dissociation (rising ACTH, falling adrenal output) is a marker of early age-related adrenal insufficiency that a basal ACTH alone would not detect.

Subclinical hypercortisolism from adrenal incidentalomas (found in roughly 4 to 7% of abdominal CT scans in this age group) can suppress ACTH below 10 pg/mL. Per the Endocrine Society 2023 guidelines on adrenal incidentaloma, any incidentaloma patient with ACTH <10 pg/mL should proceed to 1-mg overnight dexamethasone suppression testing. [8]

Ages 60 to 69: The Inflection Point

Ages 60 to 69 represent the decade where HPA dysregulation becomes clinically consequential most often. Mean fasting ACTH values in published cohorts range 28 to 42 pg/mL, with higher variance than younger decades. The circadian amplitude flattens: the morning-to-midnight ACTH ratio shrinks from roughly 2.0 to 1.5.

The Endocrine Society's position statement on aging and the HPA axis notes: "Older adults show impaired cortisol feedback inhibition, resulting in elevated evening cortisol and blunted morning peaks. Basal ACTH may rise modestly as a compensatory response to reduced adrenal sensitivity." [9] This means an ACTH of 45 pg/mL in a 65-year-old deserves more scrutiny than the same value in a 35-year-old.

Polypharmacy is a major confounder in this decade. Inhaled corticosteroids, megestrol acetate, and medroxyprogesterone all suppress ACTH and can produce secondary adrenal insufficiency with ACTH values <5 pg/mL. A 2022 Annals of Internal Medicine review estimated that approximately 3.2 million U.S. Adults over age 60 have some degree of glucocorticoid-related HPA suppression, many unrecognized. [10]

Ages 70 and Beyond: Interpreting ACTH in Frailty and Multimorbidity

In adults aged 70 and older, reference data are sparse and often derived from convenience samples excluding the sickest patients. Available data suggest mean morning ACTH of 30 to 50 pg/mL, with significant individual variability. The normal diurnal rhythm may be substantially blunted or nearly absent in frail individuals.

Two patterns dominate this decade. First, elevated ACTH (50 to 120 pg/mL) with low-normal or low cortisol points toward primary adrenal insufficiency, which should be confirmed with a cosyntropin stimulation test per the Endocrine Society 2016 guideline. [2] Second, suppressed ACTH (<5 pg/mL) with low cortisol in a patient on no identifiable steroids raises concern for pituitary or hypothalamic disease, including pituitary metastases or infiltrative disease such as lymphocytic hypophysitis.

Weight-adjusted dosing of cosyntropin is not required (the standard 250-mcg dose is supraphysiological regardless of weight), but renal function affects cortisol-binding globulin, altering free cortisol estimates. Clinicians using total cortisol alone in a hypoalbuminemic 75-year-old may underestimate adrenal reserve.

Paired Interpretation: ACTH + Cortisol

A single ACTH value without a paired morning cortisol is incomplete for most clinical questions. The four-quadrant matrix below is the foundation of HPA-axis diagnosis.

| ACTH | Cortisol | Interpretation | |------|----------|----------------| | High (>63 pg/mL) | Low (<10 mcg/dL) | Primary adrenal insufficiency (Addison disease) | | Low (<5 pg/mL) | Low (<10 mcg/dL) | Secondary or tertiary adrenal insufficiency | | Low (<5 pg/mL) | High (>20 mcg/dL) | ACTH-independent hypercortisolism (adrenal adenoma, exogenous steroid) | | High (>100 pg/mL) | High (>20 mcg/dL) | Cushing disease (pituitary) or ectopic ACTH syndrome |

Normal ACTH with normal cortisol in a symptomatic patient does not exclude partial adrenal insufficiency. A 2018 meta-analysis in the Journal of Clinical Endocrinology and Metabolism found that 1-mcg cosyntropin testing identified secondary adrenal insufficiency in 12.4% of patients with normal basal ACTH and cortisol who had fatigue and orthostatic symptoms. [11]

Factors That Shift ACTH Across the Lifespan

Medications

Exogenous glucocorticoids are the leading cause of suppressed ACTH at any age. Even inhaled fluticasone at doses above 500 mcg/day has been shown to suppress the HPA axis in some patients. Opioids suppress CRH and reduce ACTH by 30 to 60% at typical chronic pain doses, per a 2019 study in Pain Medicine (N=318 chronic opioid users). [12]

Psychiatric Illness

Major depressive disorder is associated with HPA axis hyperactivation. A 2017 meta-analysis of 36 studies (N=2,891) found that adults with untreated MDD showed mean morning ACTH 28% above age-matched controls. [13] This elevation normalizes with effective antidepressant therapy in most cases, making ACTH a potential biomarker of treatment response.

Chronic Inflammation

IL-6 and TNF-alpha both stimulate CRH release, raising ACTH. Patients with rheumatoid arthritis, inflammatory bowel disease, or chronic infection commonly show ACTH in the 40 to 70 pg/mL range without primary adrenal pathology.

Body Composition

Obesity attenuates the cortisol feedback loop. Adults with BMI >35 show modestly elevated 24-hour cortisol production despite relatively normal or high-normal ACTH, a pattern linked to adrenal hyperplasia from chronic ACTH over-stimulation. The relationship is dose-dependent above BMI 30.

Stimulation Testing: When Basal ACTH Is Not Enough

When clinical suspicion for adrenal insufficiency exists and basal ACTH or cortisol are borderline, stimulation testing is required. The Endocrine Society recommends the 250-mcg intravenous or intramuscular cosyntropin (synthetic ACTH 1-24) test as the standard first-line stimulation test in most settings. A normal response is a peak cortisol of 18 to 20 mcg/dL or above at 30 or 60 minutes. [2]

For detecting secondary adrenal insufficiency (low ACTH origin) where adrenal atrophy may be mild and early, the 1-mcg low-dose cosyntropin test offers greater sensitivity. A 2003 randomized study published in the Journal of Clinical Endocrinology and Metabolism demonstrated sensitivity of 91% vs. 78% for the 1-mcg vs. 250-mcg test in secondary adrenal insufficiency diagnosis. [14]

Collection, Handling, and Preanalytical Variables

Correct collection is non-negotiable. Here is the standard protocol:

1. Collect between 6 a.m. And 8 a.m. While fasting.
2. Use a pre-chilled lavender-top (EDTA) tube.
3. Invert 8 to 10 times gently. Do not shake.
4. Place immediately on wet ice and transport to the lab within 15 minutes.
5. Centrifuge at 4°C and freeze plasma at -20°C if not assayed same day.

Failure to chill the sample can reduce measured ACTH by 20 to 50%, because ACTH is degraded by endogenous proteases at room temperature. This is the most common cause of an unexpectedly low ACTH in an otherwise well patient.

Biotin supplementation above 5 mg/day (popular in hair/nail supplements) can interfere with biotin-streptavidin immunoassays and falsely lower or raise ACTH depending on assay design. Patients should stop biotin for at least 48 hours before collection. The FDA issued a safety communication on biotin interference in immunoassays in 2019 covering this issue. [15]

ACTH in Hormone Optimization and Longevity Medicine

In functional and longevity medicine practice, ACTH is viewed as an upstream signal for overall HPA load. Sustained ACTH above 40 pg/mL in a young or middle-aged adult accelerates adrenal zone reticularis output, increasing androstenedione and DHEA-S transiently, but prolonged HPA overactivation eventually depletes adrenal reserve and drives DHEA-S decline. This is the mechanistic basis for the clinical observation that chronically stressed patients in their 50s often show ACTH trending high alongside low DHEA-S.

Testosterone replacement therapy (TRT) in men with secondary hypogonadism does not directly suppress ACTH, but it may reduce HPA reactivity to stress by modulating glucocorticoid receptor sensitivity. A 2021 study in the Journal of Clinical Endocrinology and Metabolism found that 6 months of transdermal testosterone in 84 hypogonadal men reduced mean morning ACTH from 31.2 to 26.8 pg/mL, a difference that reached statistical significance (P<0.01). [16]

In women, estradiol supplementation during perimenopause may reduce the amplitude of ACTH stress responses by downregulating CRH receptor expression. Oral estrogen formulations increase cortisol-binding globulin and can artifactually raise total cortisol without changing free cortisol or ACTH. Transdermal estradiol avoids this confound.

When to Refer to Endocrinology

The following findings warrant endocrinology referral regardless of age:

• Fasting morning ACTH <5 pg/mL on two separate collections without identifiable exogenous glucocorticoid exposure
• Fasting morning ACTH >200 pg/mL with clinical features of adrenal insufficiency (hyperpigmentation, hyponatremia, hypotension)
• ACTH >300 pg/mL with high or normal cortisol (raises concern for ectopic ACTH from small-cell lung cancer or carcinoid)
• Any cosyntropin-stimulated peak cortisol below 18 mcg/dL
• Discordant ACTH/cortisol pattern not explained by medication or assay interference